Expression of NMDA receptor subunits in human peripheral blood lymphocytes in opioid addiction

European Journal of Pharmacology

Volumn 638, Issue 1-3, 2010, Pages 29-32

  Roozafzoon, Reza ^a,b   Goodarzi, Ali ^b,c   Vousooghi, Nasim ^b,d   Sedaghati, Mahmoud ^a,b   Yaghmaei, Parichehr ^a   Zarrindast, Mohammad Reza ^a,c,d,e,f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Sina Cellular and Molecular Research Center   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

Author keywords

Human lymphocytes; MRNA expression; NMDA receptors; NR2A; NR3A; Opioid addiction

Indexed keywords

MESSENGER RNA; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 3A; OPIATE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ABSTINENCE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION; BLOOD; LYMPHOCYTE; METABOLISM;

BIOLOGICAL MARKERS; DOWN-REGULATION; HUMANS; LYMPHOCYTES; MALE; OPIOID-RELATED DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 77953537038     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.017     Document Type: Article

References (31)

1. American Psychiatric Institute Diagnostic and Statistical Manual of Mental Disorder 1994, American Psychiatric Institute, Washington, DC. fourth ed.
2. Bajo M., Crawford E.F., Roberto M., Madamba S.G., Siggins G.R. Chronic morphine treatment alters expression of N-methyl-d-aspartate receptor subunits in the extended amygdala. J. Neurosci. Res. 2006, 83:532-537.
3. Biermann T., Bonsch D., Reulbach U., Kornhuber J., Bleich S. Dopamine and N-methyl-d-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal. J. Neural Transm. 2007, 114:1081-1084.
4. Boldyrev A.A., Kazey V.I., Leinsoo T.A., Mashkina A.P., Tyulina O.V., Johnson P., Tuneva J.O., Chittur S., Carpenter D.O. Rodent lymphocytes express functionally active glutamate receptors. Biochem. Biophys. Res. Commun. 2004, 324:133-139.
5. Boldyrev A.A., Carpenter D.O., Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J. Neurochem. 2005, 95:913-918.
6. Bondy B., Ackenheil M. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia. J. Psychiatr. Res. 1987, 21:521-529.
7. Carlezon W.A., Wise R.A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci. 1996, 16:3112-3122.
8. Chuhma N., Choi W.Y., Mingote S., Rayport S. Dopamine neuron glutamate cotransmission: frequency-dependent modulation in the mesoventromedial projection. Neuroscience 2009, 164:1068-1083.
9. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., Dikkes P., Conner D.A., Rayudu P.V., Cheung W., Chen H.S., Lipton S.A., Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998, 393:377-381.
10. David V., Durkin T.P., Cazala P. Rewarding effects elicited by the microinjection of either AMPA or NMDA glutamatergic antagonists into the ventral tegmental area revealed by an intracranial self-administration paradigm in mice. Eur. J. Neurosci. 1998, 10:1394-1402.
11. Ganor Y., Besser M., Ben-Zakay N., Unger T., Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J. Immunol. 2003, 170:4362-4372.
12. Gass J.T., Olive M.F. Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol. 2008, 75:218-265.
13. Ilani T., Ben-Shachar D., Strous R.D., Mazor M., Sheinkman A., Kotler M., Fuchs S. A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:625-628.
14. Kew J.N., Kemp J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005, 179:4-29.
15. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann. N. Y. Acad. Sci. 2000, 909:186-216.
16. Kwak Y.T., Koo M.S., Choi C.H., Sunwoo I. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med. Genet. 2001, 2:3.
17. Lombardi G., Dianzani C., Miglio G., Canonico P.L., Fantozzi R. Characterization of ionotropic glutamate receptors in human lymphocytes. Br. J. Pharmacol. 2001, 133:936-944.
18. Magnusson K.R. Influence of diet restriction on NMDA receptor subunits and learning during aging. Neurobiol. Aging 2001, 22:613-627.
19. Mashkina A.P., Tyulina O.V., Solovyova T.I., Kovalenko E.I., Kanevski L.M., Johnson P., Boldyrev A.A. The excitotoxic effect of NMDA on human lymphocyte immune function. Neurochem. Int. 2007, 51:356-360.
20. Mason J.N., Eshleman A.J., Belknap J.K., Crabbe J.C., Loftis J.M., Macey T.A., Janowsky A. NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant mice. Alcohol. Clin. Exp. Res. 2001, 25:651-660.
21. Miglio G., Varsaldi F., Lombardi G. Human T lymphocytes express N-methyl-d-aspartate receptors functionally active in controlling T cell activation. Biochem. Biophys. Res. Commun. 2005, 338:1875-1883.
22. Miyamoto Y., Yamada K., Nagai T., Mori H., Mishina M., Furukawa H., Noda Y., Nabeshima T. Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. Eur. J. Neurosci. 2004, 19:151-158.
23. Mueller H.T., Meador-Woodruff J.H. Distribution of the NMDA receptor NR3A subunit in the adult pig-tail macaque brain. J. Chem. Neuroanat. 2005, 29:157-172.
24. Nagai Y., Ueno S., Saeki Y., Soga F., Hirano M., Yanagihara T. Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 1996, 46:791-795.
25. Nilsson A., Eriksson M., Muly E.C., Akesson E., Samuelsson E.B., Bogdanovic N., Benedikz E., Sundstrom E. Analysis of NR3A receptor subunits in human native NMDA receptors. Brain Res. 2007, 1186:102-112.
26. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
27. Rigby M., Le Bourdelles B., Heavens R.P., Kelly S., Smith D., Butler A., Hammans R., Hills R., Xuereb J.H., Hill R.G., Whiting P.J., Sirinathsinghji D.J. The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience 1996, 73:429-447.
28. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 1999, 22:521-527.
29. Storto M., de Grazia U., Battaglia G., Felli M.P., Maroder M., Gulino A., Ragona G., Nicoletti F., Screpanti I., Frati L., Calogero A. Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J. Neuroimmunol. 2000, 109:112-120.
30. Tzschentke T.M., Schmidt W.J. Glutamatergic mechanisms in addiction. Mol. Psychiatry 2003, 8:373-382.
31. Zhu H., Jang C.G., Ma T., Oh S., Rockhold R.W., Ho I.K. Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment. Eur. J. Pharmacol. 1999, 365:47-54.